NOW vs PANW: Which Is the Better Buy?

Side-by-side comparison of ServiceNow, Inc. and Palo Alto Networks, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
VS
Palo Alto Networks, Inc. Β· Technology
$374.74
-5.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
NOW has more upside to fair value (+16.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NOW PANW
Current Price $139.82 $374.74
Fair Value Estimate $162.50 $355.11
Upside to Fair Value +16.2% -5.2%
Market Cap $144.6B $305.4B
Forward P/E β€” β€”
EV / EBITDA 43.1x 569.8x
Price / Sales 9.8x 26.6x
Price / FCF 31.5x 64.0x
Revenue Growth YoY +24.0% +34.4%
Gross Margin 74.8% 70.4%
Operating Margin 11.4% 6.1%
Return on Equity 13.8% 1.7%
Dividend Yield 0% 0%
FCF Yield 3.17% 1.56%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
PANW β€” Palo Alto Networks, Inc.
Palo Alto Networks is a global cybersecurity leader built around next-generation firewalls, the Panorama management platform, and a broad subscription portfolio spanning threat prevention, cloud security, secure access, and security analytics, sold to medium and large enterprises, service providers, and governments through direct and channel distribution. The business quality is genuinely high on…
Accumulation Zones
Metric NOW PANW
Zone Low $121.88 $266.33
Zone High $138.12 $301.84
In Buy Zone? No No
← NOW Research    PANW Research β†’    All Research